DHR 2024-12-04 -1.95% v -1d 9 10077.6k -8.79% 2018-10-18 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=DHR&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=DHR&ty=c&ta=1&p=d
TMO 2024-12-04 -1.04% v 4d 4 9866.8k -5.36% 2018-10-24 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=TMO&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=TMO&ty=c&ta=1&p=d
ILMN 2024-12-04 1.46% v 1d 2 3693.2k -14.63% 2018-10-23 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=ILMN&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=ILMN&ty=c&ta=1&p=d
DXCM 2024-12-04 0.14% v 3d 15 3565.7k -11.05% 2018-11-07 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=DXCM&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=DXCM&ty=c&ta=1&p=d
A 2024-12-04 0.80% v 9d 7 3269.4k -6.58% 2018-11-19 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=A&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=A&ty=c&ta=1&p=d
IQV 2024-12-04 1.12% v 1d None 2914.4k -6.42% 2018-10-25 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=IQV&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=IQV&ty=c&ta=1&p=d
IDXX 2024-12-04 0.45% v 3d 8 2340.3k -6.95% 2018-11-01 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=IDXX&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=IDXX&ty=c&ta=1&p=d
SYNH 2023-06-16 -0.02% v 6d None 2171.7k -46.25% 2018-11-08 diagnostics & research
http://finviz.com/quote.ashx?t=SYNH&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=SYNH&ty=c&ta=1&p=d
WAT 2024-12-04 1.28% v 1d 7 2169.5k -7.15% 2018-10-23 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=WAT&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=WAT&ty=c&ta=1&p=d
MTD 2024-12-04 0.43% v 5d 10 1998.7k -9.11% 2018-11-01 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=MTD&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=MTD&ty=c&ta=1&p=d
ICLR 2024-12-04 1.14% v 1d 6 1983.5k -7.04% 2018-10-25 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=ICLR&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=ICLR&ty=c&ta=1&p=d
EXAS 2024-12-04 6.18% v 1d 42 1753.0k -9.90% 2018-10-29 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=EXAS&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=EXAS&ty=c&ta=1&p=d
LH 2024-12-04 -1.40% v -1d 4 1675.3k -5.94% 2018-10-24 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=LH&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=LH&ty=c&ta=1&p=d
DGX 2024-12-04 -1.06% v -1d 10 1511.2k -6.80% 2018-10-23 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=DGX&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=DGX&ty=c&ta=1&p=d
CRL 2024-12-04 0.07% v 6d 8 1358.8k -10.22% 2018-11-08 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=CRL&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=CRL&ty=c&ta=1&p=d
GH 2024-12-04 6.61% v 1d None 1351.7k -27.14% 2021-02-26 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=GH&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=GH&ty=c&ta=1&p=d
PKI 2023-05-15 -0.91% v -6d 10 1308.3k -6.79% 2018-11-01 diagnostics & research
http://finviz.com/quote.ashx?t=PKI&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=PKI&ty=c&ta=1&p=d
LNTH 2024-12-04 0.36% v -2d 47 1023.4k -13.49% 2018-11-01 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=LNTH&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=LNTH&ty=c&ta=1&p=d
MEDP 2024-12-04 1.89% v 1d 10 951.1k -20.30% 2018-10-30 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=MEDP&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=MEDP&ty=c&ta=1&p=d
TWST 2024-12-04 3.97% v 8d None 747.5k -19.92% 2021-02-05 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=TWST&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=TWST&ty=c&ta=1&p=d
NVTA 2023-06-16 -2.36% v 6d 693.1k -47.74% 2018-11-05 diagnostics & research
http://finviz.com/quote.ashx?t=NVTA&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=NVTA&ty=c&ta=1&p=d
NTRA 2024-12-04 2.93% v 4d 15 581.6k -32.79% 2018-11-14 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=NTRA&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=NTRA&ty=c&ta=1&p=d
PACB 2024-12-04 13.66% v 1d 505.9k -14.85% 2018-11-01 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=PACB&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=PACB&ty=c&ta=1&p=d
QGEN 2024-12-04 1.06% v 1d 40 503.3k -5.22% 2018-11-05 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=QGEN&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=QGEN&ty=c&ta=1&p=d
QDEL 2024-12-04 -0.45% v -2d 8 379.4k -17.35% 2018-11-07 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=QDEL&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=QDEL&ty=c&ta=1&p=d
NEOG 2024-12-04 0.01% v -6d 12 371.4k -9.09% 2018-03-22 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=NEOG&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=NEOG&ty=c&ta=1&p=d
HSKA 2023-06-13 0.00% v 6d 43 322.2k -10.80% 2018-11-01 diagnostics & research
http://finviz.com/quote.ashx?t=HSKA&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=HSKA&ty=c&ta=1&p=d
CSTL 2024-12-04 3.31% v 6d None 270.3k -48.70% 2021-11-10 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=CSTL&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=CSTL&ty=c&ta=1&p=d
CDNA 2024-12-04 4.25% v 1d 235.2k -32.72% 2018-11-08 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=CDNA&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=CDNA&ty=c&ta=1&p=d
PHG 2024-12-04 -0.45% v -2d 5 232.6k -14.65% 2018-10-22 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=PHG&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=PHG&ty=c&ta=1&p=d
SHC 2024-12-04 3.39% v -8d None 216.0k -33.27% None diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=SHC&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=SHC&ty=c&ta=1&p=d
RDNT 2024-12-04 0.44% v 8d 1 199.7k -11.18% 2018-11-08 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=RDNT&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=RDNT&ty=c&ta=1&p=d
NEO 2024-12-04 1.12% v 6d 177.4k -29.79% 2018-10-30 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=NEO&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=NEO&ty=c&ta=1&p=d
BNGO 2024-12-03 -6.80% v -1d None 155.7k -33.58% 2021-11-13 diagnostics & research
http://finviz.com/quote.ashx?t=BNGO&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=BNGO&ty=c&ta=1&p=d
MYGN 2024-12-04 2.65% v 1d 13 147.9k -16.78% 2018-11-06 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=MYGN&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=MYGN&ty=c&ta=1&p=d
FLGT 2024-12-04 3.84% v 4d 132.3k -11.93% 2018-11-05 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=FLGT&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=FLGT&ty=c&ta=1&p=d
NOTV 2024-12-04 -7.04% v 2d None 124.2k -56.97% 2021-05-06 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=NOTV&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=NOTV&ty=c&ta=1&p=d
ME 2024-12-04 -2.01% v 2d None 121.4k -20.33% None diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=ME&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=ME&ty=c&ta=1&p=d
OPK 2024-12-04 -1.58% v -1d 100.3k -23.82% 2018-11-14 diagnostics & research
http://finviz.com/quote.ashx?t=OPK&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=OPK&ty=c&ta=1&p=d
HTGM 2023-06-14 -20.00% v -5d 68.0k -20.75% 2018-11-06 diagnostics & research
http://finviz.com/quote.ashx?t=HTGM&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=HTGM&ty=c&ta=1&p=d
BVS 2024-12-04 -6.01% v -2d None 67.3k -57.51% 2021-05-13 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=BVS&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=BVS&ty=c&ta=1&p=d
AWH % v d 32 60.7k -32.36% 2017-04-27 diagnostics & research
http://finviz.com/quote.ashx?t=AWH&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=AWH&ty=c&ta=1&p=d
CEMI 2023-04-27 0.22% v 1d 53.4k -60.83% 2018-11-14 diagnostics & research
http://finviz.com/quote.ashx?t=CEMI&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=CEMI&ty=c&ta=1&p=d
SENS 2024-12-03 -0.58% v -2d 52.7k -19.34% 2018-10-30 diagnostics & research
http://finviz.com/quote.ashx?t=SENS&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=SENS&ty=c&ta=1&p=d
QTNT % v d 44.5k -16.83% 2018-10-29 diagnostics & research
http://finviz.com/quote.ashx?t=QTNT&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=QTNT&ty=c&ta=1&p=d
CNTG % v d None 41.7k -33.06% 2021-12-16 diagnostics & research
http://finviz.com/quote.ashx?t=CNTG&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=CNTG&ty=c&ta=1&p=d
BIOC 2023-06-16 7.22% v -6d 39.7k -12.50% 2018-11-08 diagnostics & research
http://finviz.com/quote.ashx?t=BIOC&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=BIOC&ty=c&ta=1&p=d
SQL 2023-11-17 0.00% v -5d None 39.0k -17.47% None diagnostics & research
http://finviz.com/quote.ashx?t=SQL&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=SQL&ty=c&ta=1&p=d
TTOO 2024-12-03 -8.08% v -1d 37.9k -29.87% 2018-11-01 diagnostics & research
http://finviz.com/quote.ashx?t=TTOO&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=TTOO&ty=c&ta=1&p=d
DMTK 2023-06-16 -4.83% v -1d None 37.6k -44.67% 2020-04-09 diagnostics & research
http://finviz.com/quote.ashx?t=DMTK&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=DMTK&ty=c&ta=1&p=d
SRDX 2024-12-04 1.06% v 1d 37 35.9k -29.35% 2018-11-14 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=SRDX&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=SRDX&ty=c&ta=1&p=d
OPGN 2023-06-16 -3.23% v -1d 35.8k -19.05% 2018-11-06 diagnostics & research
http://finviz.com/quote.ashx?t=OPGN&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=OPGN&ty=c&ta=1&p=d
MXCT 2024-12-04 2.65% v 5d None 34.5k -19.78% 2021-09-14 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=MXCT&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=MXCT&ty=c&ta=1&p=d
AXDX % v d 49 34.2k -49.40% 2018-11-01 diagnostics & research
http://finviz.com/quote.ashx?t=AXDX&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=AXDX&ty=c&ta=1&p=d
SLNO 2024-12-04 -0.56% v -4d 33.0k -48.70% 2018-11-13 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=SLNO&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=SLNO&ty=c&ta=1&p=d
CHEK % v d 30.7k -46.12% 2018-03-29 diagnostics & research
http://finviz.com/quote.ashx?t=CHEK&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=CHEK&ty=c&ta=1&p=d
NDRA 2024-12-04 5.22% v -3d 28.4k -22.81% 2021-11-17 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=NDRA&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=NDRA&ty=c&ta=1&p=d
OLK 2023-06-16 -6.02% v -3d None 28.1k -27.79% 2021-05-20 diagnostics & research
http://finviz.com/quote.ashx?t=OLK&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=OLK&ty=c&ta=1&p=d
LHDX 2023-06-16 -12.50% v -12d None 27.6k -46.43% None diagnostics & research
http://finviz.com/quote.ashx?t=LHDX&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=LHDX&ty=c&ta=1&p=d
RNLX % v d None 26.7k -38.29% None diagnostics & research
http://finviz.com/quote.ashx?t=RNLX&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=RNLX&ty=c&ta=1&p=d
BASI % v d 25.0k -21.55% 2017-02-14 diagnostics & research
http://finviz.com/quote.ashx?t=BASI&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=BASI&ty=c&ta=1&p=d
MOTS 2023-06-16 8.71% v 1d None 24.6k -22.83% 2018-11-13 diagnostics & research
http://finviz.com/quote.ashx?t=MOTS&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=MOTS&ty=c&ta=1&p=d
PRPO % v d None 17.8k -16.67% 2021-11-20 diagnostics & research
http://finviz.com/quote.ashx?t=PRPO&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=PRPO&ty=c&ta=1&p=d
NRC 2024-12-04 2.38% v 1d None 17.1k -13.16% 2018-11-06 diagnostics & research
http://finviz.com/quote.ashx?t=NRC&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=NRC&ty=c&ta=1&p=d
STIM % v d None 16.4k -41.98% 2018-11-13 diagnostics & research
http://finviz.com/quote.ashx?t=STIM&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=STIM&ty=c&ta=1&p=d
LMDX 2023-12-29 -2.18% v 0d None 16.0k -36.97% None diagnostics & research
http://finviz.com/quote.ashx?t=LMDX&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=LMDX&ty=c&ta=1&p=d
DRIO % v d 11.4k -13.06% 2018-03-19 diagnostics & research
http://finviz.com/quote.ashx?t=DRIO&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=DRIO&ty=c&ta=1&p=d
CELC 2024-12-04 1.91% v 1d None 10.9k -21.34% 2020-03-18 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=CELC&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=CELC&ty=c&ta=1&p=d
IDXG % v d 10.5k -32.87% 2018-11-12 diagnostics & research
http://finviz.com/quote.ashx?t=IDXG&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=IDXG&ty=c&ta=1&p=d
CODX % v d None 10.3k -30.65% 2021-11-17 diagnostics & research
http://finviz.com/quote.ashx?t=CODX&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=CODX&ty=c&ta=1&p=d
GENE % v d 10.1k -15.58% 2014-08-29 diagnostics & research
http://finviz.com/quote.ashx?t=GENE&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=GENE&ty=c&ta=1&p=d
ENZ % v d 7.9k -24.32% 2018-03-12 diagnostics & research
http://finviz.com/quote.ashx?t=ENZ&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=ENZ&ty=c&ta=1&p=d
ANIX % v d None 6.6k -24.46% 2020-10-25 diagnostics & research
http://finviz.com/quote.ashx?t=ANIX&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=ANIX&ty=c&ta=1&p=d
SERA % v d None 5.9k -17.13% None diagnostics & research
http://finviz.com/quote.ashx?t=SERA&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=SERA&ty=c&ta=1&p=d
BNR 2024-12-04 13.67% v 1d None 5.9k -18.40% 2021-11-20 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=BNR&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=BNR&ty=c&ta=1&p=d
ONVO % v d 4.2k -17.86% 2018-11-08 diagnostics & research
http://finviz.com/quote.ashx?t=ONVO&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=ONVO&ty=c&ta=1&p=d
BWAY 2024-12-04 1.37% v 0d None 4.1k -31.56% 2021-11-18 diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=BWAY&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=BWAY&ty=c&ta=1&p=d
BEAT % v d 2 3.9k -22.13% 2018-11-06 diagnostics & research
http://finviz.com/quote.ashx?t=BEAT&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=BEAT&ty=c&ta=1&p=d
VNRX % v d 3.6k -20.36% 2018-11-08 diagnostics & research
http://finviz.com/quote.ashx?t=VNRX&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=VNRX&ty=c&ta=1&p=d
BDSX % v d None 2.0k -26.32% None diagnostics & research
http://finviz.com/quote.ashx?t=BDSX&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=BDSX&ty=c&ta=1&p=d
BMRA % v d 1.7k -22.54% 2018-10-15 diagnostics & research
http://finviz.com/quote.ashx?t=BMRA&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=BMRA&ty=c&ta=1&p=d
XGN % v d None 1.6k -23.61% 2021-11-11 diagnostics & research
http://finviz.com/quote.ashx?t=XGN&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=XGN&ty=c&ta=1&p=d
ISPC 2024-12-04 -5.62% v -3d None 0.9k -22.67% None diagnostics & research diagnostics & research
http://finviz.com/quote.ashx?t=ISPC&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=ISPC&ty=c&ta=1&p=d
GTH 2023-06-16 0.55% v 4d None 0.8k -20.94% 2021-11-09 diagnostics & research
http://finviz.com/quote.ashx?t=GTH&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=GTH&ty=c&ta=1&p=d
TRIB % v d 0.5k -12.97% 2018-04-26 diagnostics & research
http://finviz.com/quote.ashx?t=TRIB&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=TRIB&ty=c&ta=1&p=d
PMD % v d 12 0.4k -7.74% 2017-02-06 diagnostics & research
http://finviz.com/quote.ashx?t=PMD&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=PMD&ty=c&ta=1&p=d
CO % v d 7 k -28.57% 2016-11-18 diagnostics & research
http://finviz.com/quote.ashx?t=CO&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=CO&ty=c&ta=1&p=d
ARA % v d 9 k -21.35% 2018-11-13 diagnostics & research
http://finviz.com/quote.ashx?t=ARA&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=ARA&ty=c&ta=1&p=d
FLDM 2022-04-05 -7.02% v -1d k -26.51% 2018-11-02 diagnostics & research
http://finviz.com/quote.ashx?t=FLDM&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=FLDM&ty=c&ta=1&p=d
OCDX 2022-05-26 0.46% v -1d None k -9.54% None diagnostics & research
http://finviz.com/quote.ashx?t=OCDX&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=OCDX&ty=c&ta=1&p=d
OXFD % v d 53 k -11.14% 2018-10-30 diagnostics & research
http://finviz.com/quote.ashx?t=OXFD&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=OXFD&ty=c&ta=1&p=d
PRAH % v d 1 k -19.42% 2018-11-01 diagnostics & research
http://finviz.com/quote.ashx?t=PRAH&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=PRAH&ty=c&ta=1&p=d
VIVO 2023-01-31 0.00% v 3d 37 k -22.89% 2018-11-08 diagnostics & research
http://finviz.com/quote.ashx?t=VIVO&ty=c&ta=1&p=m http://finviz.com/quote.ashx?t=VIVO&ty=c&ta=1&p=d